Following a selection process led by a panel of Angel Investors, ViRAZE was one of 24 companies selected to participate in the annual Angel Venture Fair being held at the Union League in Philadelphia.
ViRAZE is an emerging biotechnology company utilizing a patented high throughput screening (HTS) technology to discover and develop first-in-class new small molecules to treat viral diseases. Please visit our website for further information: https://viraze.net/
About Angel Venture Fair (AFV)
The Angel Venture Fair brings together the largest gathering of Angel Investors and Entrepreneurs in the Mid-Atlantic region,. The AVF takes place Tuesday April 26th at the Union League from 7:30 a.m. to 4 p.m., has worked with over 500 companies over the last 18 years. : http://www.angelventurefair.com